FINIXIN 5G/100ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΒΟΟΕΙΔΗ, ΙΠΠΟΕΙΔΗ ΚΑΙ ΧΟΙΡΟΥΣ
FINIXIN 5G/100ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΒΟΟΕΙΔΗ, ΙΠΠΟΕΙΔΗ ΚΑΙ ΧΟΙΡΟΥΣ
Authorised
- Flunixin meglumine
Product identification
Medicine name:
FINIXIN 5G/100ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΒΟΟΕΙΔΗ, ΙΠΠΟΕΙΔΗ ΚΑΙ ΧΟΙΡΟΥΣ
Active substance:
- Flunixin meglumine
Target species:
-
Pig
-
Equid
-
Cattle
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Flunixin meglumine8.50gram(s)100.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
-
Meat and offal24day
-
-
Intravenous use
- Equid
-
Meat and offal2day
-
- Cattle
-
Meat and offal4day
-
Milk24hour
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AG90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
- Trirx Segre
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 61766/05-09-2012/K-0058601
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: